The Technical Analyst
Intelligent Bio Solutions [INBS]
Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Medical - Diagnostics & Research
Intelligent Bio Solutions Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
4.84% $2.60
/ 7 mai 2024 @ 11:22
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 7.40 mill |
| EPS: | 64.68 |
| P/E: | 0.0400 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 2.84 mill |
| Avg Daily Volume: | 1.683 mill |
| RATING 2024-05-06 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0.0400 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 0.0400 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-1.347 (-151.80%) $-3.95 |
| Date: 2024-05-07 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.19 - 3.01 ( +/- 15.77%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-20 | Sakiris Spiro Kevin | Buy | 9 394 | Common Stock |
| 2024-03-20 | Sakiris Spiro Kevin | Sell | 9 394 | Common Stock Warrants (Series F) |
| 2023-10-04 | Sakiris Spiro Kevin | Buy | 0 | |
| 2023-10-04 | Towers Christopher | Buy | 9 090 | Common Stock |
| 2023-10-04 | Towers Christopher | Buy | 9 090 | Common Stock Warrants (Series E) |
| INSIDER POWER |
|---|
| 88.14 |
| Last 14 transactions |
| Buy: 377 394 | Sell: 25 387 |
Forecast:
13:01 - $2.59
Live Trading Signals (every 1 min)
Forecast
1: 11:31 - $2.63
Forecast 2: 12:21 - $2.64
Forecast 3: 13:01 - $2.59
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.60 (4.84% ) |
| Volume | 0.0343 mill |
| Avg. Vol. | 1.683 mill |
| % of Avg. Vol | 2.04 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INBS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:33 | buy | $2.82 | N/A | Active |
|---|
INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Latest Press Releases
2024-04-18 08:30:00 - Press Release
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter And Nine-month Revenue Results
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended march 31, 2024, with highest quarterly cartridge sales since 2022 intelligent fingerprinting acquisition year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended march 31, 2024, with highest quarterly cartridge sales since 2022 intelligent fingerprinting acquisition
2024-04-11 08:30:00 - Press Release
Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio With Grant Of New European Patent With Unitary Effect For Innovative Intelligent Fingerprinting Dsr-plus Cartridge Reader
New york, april 11, 2024 (globe newswire) -- intelligent bio solutions inc. (“inbs” or the “company”) (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, intelligent fingerprinting limited, with the grant of a new european patent with unitary effect for its ground-breaking dsr-plus cartridge reader. this latest achievement follows the successful protection of the same technology in the united kingdom and marks another significant milestone in the company's expansion and protection of its intellectual property.
2024-03-26 08:30:00 - Press Release
Intelligent Bio Solutions To Present At The Ld Micro Invitational Xiv Investor Conference On April 9 In Nyc
New york, march 26, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that president and ceo, harry simeonidis, and cfo, spiro sakiris, are scheduled to present at the ld micro invitational xiv investor conference to be held on april 8-9, 2024 in new york city.
2024-03-12 19:30:00 - Press Release
Intelligent Bio Solutions Announces Closing Of $10.1 Million Private Placement Priced At-the-market Under Nasdaq Rules
New york, march 12, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced private placement priced at-the-market under nasdaq rules of 2,223,333 shares of common stock (or pre-funded warrants in lieu thereof), series h-1 warrants to purchase up to an aggregate of 2,223,333 shares of common stock and series h-2 warrants to purchase up to an aggregate of 2,223,333 shares of common stock, at a combined purchase price of $4.55 per share of common stock (or pre-funded warrant) and associated series h-1 warrants and series h-2 warrants...
2024-03-11 08:30:00 - Press Release
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced at-the-market Under Nasdaq Rules
New york, march 11, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that on march 8, 2024, it entered into securities purchase agreements with several healthcare-focused institutional and accredited investors to issue, in a private placement priced at-the-market under nasdaq rules, 2,223,333 shares of common stock (or pre-funded warrants in lieu thereof), series h-1 warrants to purchase up to an aggregate of 2,223,333 shares of common stock and series h-2 warrants to purchase up to an aggregate of 2,223,333 shares of common stock, at a combined purchase price of $4...
Latest News
2024-03-26 08:30:00 - GlobeNewsWire
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024 in New York City.
2024-03-01 08:30:00 - GlobeNewsWire
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on March 6, 2024. INBS will provide an update on the Company's growth and financial performance in 2023, among other topics.
2024-02-12 09:01:14 - InvestorPlace
Why Is Intelligent Bio Solutions (INBS) Stock Down 24% Today?
Intelligent Bio Solutions (NASDAQ: INBS ) stock is falling on Monday following the release of the medical technology company's earnings report for its fiscal second quarter of 2024. The Intelligent Bio Solutions earnings release includes adjusted earnings per share of -$2.07.
2023-11-29 08:30:00 - GlobeNewsWire
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on December 7, 2023. The Company will provide insight into the Company's unique proprietary Intelligent Fingerprinting Drug Screening System, among other topics.
2023-03-08 09:09:58 - InvestorPlace
Why Is Intelligent Bio Solutions (INBS) Stock Down 48% Today?
Intelligent Bio Solutions (NASDAQ: INBS ) stock is taking a beating on Wednesday after the company announced a proposed public stock offering. The company announced that offering yesterday, and then released details of the offering early this morning.
2023-02-07 09:12:37 - PennyStocks
7 Penny Stocks To Watch With Big News In February; Time To Buy?
Penny stocks to watch with news this month. The post 7 Penny Stocks To Watch With Big News In February; Time To Buy?
2023-01-31 09:30:53 - PennyStocks
7 Top Penny Stocks To Watch With Big News This Week
2023-01-25 06:00:00 - PennyStocks
The Benefits of Short Term Trading Penny Stocks
Should you use a short term penny stocks trading strategy? The post The Benefits of Short Term Trading Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-01-24 06:00:00 - PennyStocks
These Tips Could Make You Money With Penny Stocks
Use these tips to help make money with penny stocks in 2023 The post These Tips Could Make You Money With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-01-23 11:31:51 - InvestorPlace
Why Is Intelligent Bio Solutions (INBS) Stock Up 363% Today?
Intelligent Bio Solutions (NASDAQ: INBS ) stock is rocketing higher on Monday thanks to a new milestone for the biosensor company. As detailed in a press release, the development of Intelligent Bio Solutions' biosensor platform is going well.